John E. Lux, Esq K Street, Suite 300 Washington, DC Lux Law, pa (202)
|
|
- Buddy Paul
- 5 years ago
- Views:
Transcription
1 John E. Lux, Esq K Street, Suite 300 Washington, DC Lux Law, pa (202) john.lux@securitieslaw.info February 28, 2018 OTC Markets Group Inc. 304 Hudson Street. 2nd Floor New York, New York Re: HempAmericana, Inc. (OTC: HMPQ) To Whom It May Concern: We have been retained as corporate counsel for HempAmericana, Inc., a Delaware corporation (the Company ) beginning as of October 27,, and have been asked to render a legal opinion to OTC Markets Group, Inc. ( OTC Markets ) with respect to recent information publicly disclosed by the Company and published in the OTC Disclosure and News Service. OTC Markets is entitled to rely on this letter in determining whether the Company has made adequate current information publicly available within the meaning of Rule 144(c) (2) under the Securities Act of 1933, as amended ( Securities Act ). I am a U.S. resident. I am licensed to practice law in the State of Maryland and the District of Columbia and I have not been prohibited from practicing before the U.S. Securities and Exchange Commission ( SEC ). We have been retained by the Company for general corporate advisory work, and we also agree to represent the Company for the purpose of reviewing and rendering a legal opinion as to the current information supplied by the Company. I have examined such corporate records and other documents and such questions of law as counsel considered necessary or appropriate for purposes of rendering the letter. As to matters of fact, I have relied on information obtained from public officials, officers of the Issuer and other sources, and I believe all such sources are reliable. 1
2 The specific documents and dates that such documents were posted containing the information concerning the Issuer and the Securities that are publicly available through the OTC Disclosure & News Service that I have reviewed in connection with the preparation of the letter (the Information ) are as follows: 01/11/18 Oct 16, Sep 8, Aug 1, Aug 1, Jul 11, Apr 13, Feb 8, Jan 31, ending 11/30/17 Nov 30, ending 8/31/17 Aug 31, Supplemental Information - Maine Joint Venture Agreement Sept 8, Executed Attorney Letter with Respect to Current Information - Attorney letter with respect to current information Feb 28, Quarterly Report - Ammended 1st quarter 5/31/ May 31, ending 5/31/17 Annual Report - Financial Statments and Notes for the Year Ending February 28, Quarterly Report - Ammended 3rd quarter ending November 30, 2016 Quarterly Report - Financial Statments and Notes for the Period Ending November 30, 2016 May 31, Feb 28, Nov 30, 2016 Nov 30, 2016 Additionally, I have reviewed the filings of the Issuer under Regulation A with the U.S. Securities and Exchange Commission in the EDGAR system: QUALIF Notice of Qualification [Regulation A] Acc-no: (33 Act) Size: 1 KB Acc-no: Size: 5 KB Acc-no: (33 Act) Size: 479 KB Acc-no: Size: 41 KB Acc-no: (33 Act) Size: 568 KB [Amend] [Cover]Offering Statement [Regulation A]
3 1-A Acc-no: (33 Act) Size: 574 KB Acc-no: Size: 163 KB Acc-no: (33 Act) Size: 572 KB Acc-no: Size: 31 KB Acc-no: Size: 139 KB Acc-no: (33 Act) Size: 773 KB Acc-no: Size: 9 KB Acc-no: Size: 43 KB Offering Statement [Regulation A] Acc-no: (33 Act) Size: 24 MB The Information (i) constitutes adequate current public information concerning the Securities and the Issuer and is available within the meaning of Rule 144(c)(2) under the Securities Act, (ii) includes all of the information that a broker-dealer would be required to obtain from the Issuer to publish a quotation for the Securities under Rule 15c2-11 under the Securities Exchange Act of 1934 (the Exchange Act ), (iii) complies as to form with the OTC Markets Group s OTC Pink Disclosure Guidelines, which are located on the Internet at and (iv) has been posted through the OTC Disclosure &News Service. The person responsible for the preparation of the financial statements contained in the Information is Richard Edelson of Get OTC Current, LLC. Mr. Edelson s many years of financial industry experience and his knowledge of finance and accounting qualify him to prepare the Company s unaudited financial statements. The Issuer s transfer agent is Olde Monmouth Stock Transfer Co., Inc., 200 Memorial Pkwy. Atlantic Heights, NJ 07716, , matt@oldemonmouth.com. I confirm that the transfer agent is registered with the SEC, and I have confirmed the number of outstanding shares set forth in the Information by inspecting a recent shareholder list from the transfer agent. I have (i) personally met with management and a majority of the directors of the Issuer, (ii) reviewed the Information, as amended, published by the Issuer through the OTC 3
4 Disclosure &News Service and (iii) discussed the Information with management and a majority of the directors of the Issuer. To the best of my knowledge, after inquiry of management and the directors of the Issuer, none of the Issuer of the Securities, any 5% holder, or counsel is currently under investigation by any federal or state regulatory authority for any violation of federal or states securities laws. No person other than OTC Markets Group is entitled to rely on this letter. OTC Markets Group is granted full and complete permission and rights to publish the letter through the OTC Disclosure & News Service for viewing by the public and regulators. Current Information for Promoted Security Control persons: Name Business Address number and class of the Issuer s securities beneficially owned Restrictive Legend on Certificate Consideration received by the Issuer Salvador Rosillo President 9,080,000 Class A Common Stock 108,000,000 Class B Nieves Rosillo Secretary 10,108,000 Class A Africement, Inc. an entity wholly owned by Salvador Rosillo 404,920,000 Class A 4
5 For purposes of this letter, the term control person includes (i) any person controlling, under common control with, or controlled by, the Issuer or (ii) any person who obtained securities of the Issuer in connection with a negotiation with the Issuer within the threeyear period prior to the date of the opinion. The company engaged Seaside Advisors for investor relations. Seaside Advisors is located at 1 Lakeside Avenue, Rumson, NJ and is owed by Lawrence Adams of the same address. It is a single member limited liability company. Neither Seaside or Mr. Adams own any securities in the Company. I have made specific inquiry of each of the persons listed in above, persons engaged in promotional activities regarding the Issuer, and persons owning more than ten percent (10%) of the Securities (collectively, the Insiders ), and based upon such inquiries and other information available to me, any sales of the Securities by Insiders within the twelve-month period prior to the opinion have been made in compliance with Rule 144, including, without limitation, any required filings of Form 144, and nothing has come to my attention indicating that any of the Insiders is in possession of any material nonpublic information regarding the Issuer or the Securities that would prohibit any of them from buying or selling the Securities under Rules 10b-5 or 10b5-1 under the Exchange Act. Kindly contact me if further information is needed. Sincerely, Jo John E. Lux 5
QUARTERLY REPORT HEMPAMERICANA, INC.
QUARTERLY REPORT HEMPAMERICA, INC. 1. Name of the issuer. HempAmericana, Inc. 2. The address of the issuer s principal executi offices. 78 Reade Street Suite 4FW, NY 10007 929-243-6586 - Telephone available
More informationATTORNEY LETTER AGREEMENT
ATTORNEY LETTER AGREEMENT THIS AGREEMENT, dated as of the date executed by PINK SHEETS LLC ( Pink Sheets ), a limited liability company organized under the laws of the State of Delaware, located at 304
More informationJohn T. Root, Jr. ATTORNEY AT LAW
John T. Root, Jr. ATTORNEY AT LAW P.O. Box 701 Greenbrier, Arkansas 72058 Phone: (501) 529-8567 Fax: (501) 325-1130 j.root.5013@gmail.com Issuer Services 304 Hudson Street New York, NY 10013 Re: Pure Hospitality
More informationATTORNEYS AT LAW, L.L.C.
TRENT J. WADDOUPS TAYLOR D. CARR (1944 2001) CARR & WADDOUPS ATTORNEYS AT LAW, L.L.C. 609 JUDGE BUILDING 8 EAST BROADWAY SALT LAKE CITY, UTAH 84111 TELEPHONE (801) 363-0888 FACSIMILE (801) 363-8512 OTC
More informationQUARTERLY REPORT HEMPAMERICANA, INC.
QUARTERLY REPORT HEMPAMERICA, INC. 1. Name of the issuer. HempAmericana, Inc. 2. The address of the issuer s principal executive offices. 78 Reade Street Suite 4FW, NY 10007 929-243-6586 - Telephone Not
More informationSeptember 8, Pink OTC Markets, Inc. 304 Hudson Street Second Floor New York, New York 10013
DIANE D. DALMY ATTORNEY AT LAW 8965 W. CORNELL PLACE LAKEWOOD, COLORADO 80227 303.985.9324 (telephone) 303.988.6954 (facsimile) email: ddalmy@earthlink.net Pink OTC Markets, Inc. 304 Hudson Street Second
More informationSTEPHEN MILLS Attorney at Law PO Box Nashville, TN November 4, 2016
STEPHEN MILLS Attorney at Law PO Box 281077 Nashville, TN 37228 615-366-0690 November 4, 2016 OTC MARKET GROUPS, INC. RE: NORTH SPRINGS RESOURCE CORP. (NSRS) ANNUAL DISCLOSURE 2016 Dear Sir or Madam: We
More informationLAW OFFICE THOMAS J. BEENER 390 OAK UNIT O CARLSBAD, CA
LAW OFFICE THOMAS J. BEENER 390 OAK UNIT O CARLSBAD, CA 92008 760-715-0726 Tom.beener.law@gmail.com March22, 2017 OTC Markets Group, Inc. 304 Hudson Street 2 nd Floor New York, NY 10013 RE: Kimberly Parry
More informationSANTACROCE LAW OFFICES, LTD
Frederick A. Santacroce, Esq. 3275 S. Jones Blvd Suite 104 Las Vegas NV 89146 Tel 702-218-3360 fasatty@yahoo.com NV Bar No. 5121 VIA TELECOPIER AND EMAIL February 1, 2018 OTC Markets Group, Inc. 304 Hudson
More informationFebruary 5, 2019 VIA . OTC Markets Group Inc. 304 Hudson Street Second Floor New York, NY 10013
February 5, 2019 VIA EMAIL OTC Markets Group Inc. 304 Hudson Street Second Floor New York, NY 10013 Re: American Energy Partners, Inc. Sufficiency of Adequate Current Information Dear OTC Markets Group
More informationLegal Opinion concerning Adequate Current Information of Sino Bioenergy Corp. (Symbol SFBE)
Law Offices of Dieterich & Associates 11835 W. Olympic Boulevard Suite 1235E Christopher Dieterich Los Angeles, California 90064 Of Counsel Mike Khalilpour (310) 312-6888 J. John Combs Bryon Y. Chung FAX
More informationOTCQX RULES FOR INTERNATIONAL COMPANIES
OTCQX RULES FOR INTERNATIONAL COMPANIES TABLE OF CONTENTS 1 GENERAL CONSIDERATIONS 2 1.1 APPLICATION OF OTCQX RULES FOR INTERNATIONAL COMPANIES 2 1.2 AMENDMENT OF OTCQX RULES FOR INTERNATIONAL COMPANIES
More informationHEMPAMERICANA, INC. COMPANY INFORMATION AND DISCLOSURE STATEMENT 3rd Quarter PERIOD ENDING November 30, 2018
HEMPAMERICANA, INC. COMPANY INFORMATION AND DISCLOSURE STATEMENT 3rd Quarter PERIOD ENDING November 30, 2018 HEMPAMERICANA, INC. (a Delaware Corporation) Information provided pursuant to the OTC Guidelines
More informationOTC Pink Basic Disclosure Guidelines
OTC Pink Basic Disclosure Guidelines Federal securities laws, such as Rules 10b-5 and 15c2-11 of the Securities Exchange Act of 1934 ( Exchange Act ) as well as Rule 144 of the Securities Act of 1933 (
More informationBAUMAN & ASSOCIATES LAW FIRM
January 30,20L7 BAUMAN & ASSOCIATES LAW FIRM FREDERICK C. BAUMAN Attorney-at-Law Nevada Bar No. 8370 6440 Sky Pointe Dr., Ste 140-1,49 Las Vegas, NV 891"31U.S.A. www.lawbauman.com (702\ s33-8372 (800)
More informationCASTLE BRANDS INC Filed by CAMULOS CAPITAL LP
CASTLE BRANDS INC Filed by CAMULOS CAPITAL LP FORM SC 13G/A (Amended Statement of Ownership) Filed 2/12/9 Address 122 EAST 42ND STREET SUITE 47 NEW YORK, NY 1168 Telephone 646-356-2 CIK 1311538 Symbol
More informationRealogy Holdings Corp.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Realogy Holdings Corp. (Name of Issuer) Common Stock
More informationInvestment Advisers Act of Rule 206(4)-2. November 20, 1990 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C
Investment Advisers Act of 1940 -- Rule 206(4)-2 November 20, 1990 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 RESPONSE OF THE OFFICE OF CHIEF COUNSEL DIVISION OF INVESTMENT MANAGEMENT Wallington
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) Under the Securities Exchange Act of 1934 (Amendment No. 2)* Synergy Pharmaceuticals Inc. (Name of
More informationPREFERRED APARTMENT COMMUNITIES INC Filed by WILLIAMS OPPORTUNITY FUND LLC
PREFERRED APARTMENT COMMUNITIES INC Filed by WILLIAMS OPPORTUNITY FUND LLC FORM SC 13D/A (Amended Statement of Beneficial Ownership) Filed 04/11/12 Address 3284 NORTHSIDE PARKWAY NW SUITE 150 ATLANTA,
More informationST JOE CO Filed by THIRD AVENUE MANAGEMENT LLC
ST JOE CO Filed by THIRD AVENUE MANAGEMENT LLC FORM SC 13G (Statement of Ownership) Filed 07/10/08 Address 245 RIVERSIDE AVENUE STE 500 JACKSONVILLE, FL 32202 Telephone 9043014200 CIK 0000745308 Symbol
More informationAlgo Trading System RTM
Year Return 2016 15,17% 2015 29,57% 2014 18,57% 2013 15,64% 2012 13,97% 2011 55,41% 2010 50,98% 2009 48,29% Algo Trading System RTM 89000 79000 69000 59000 49000 39000 29000 19000 9000 2-Jan-09 2-Jan-10
More informationOTC Pink Basic Disclosure Guidelines
OTC Pink Basic Disclosure Guidelines Federal securities laws, such as Rules 10b-5 and 15c2-11 of the Securities Exchange Act of 1934 ("Exchange Act") as well as Rule 144 of the Securities Act of 1933 ("Securities
More informationAffordable Care Act Implementation Alert
CONTENTS > What is the PCORI Fee? What is the purpose of the PCORI fee? > What are the reporting and payment requirements? > How is the PCORI fee calculated? > What is the role of AmeriHealth Administrators?
More information1 Requirements for Admission to OTCQB
OTCQB Standards The OTCQB Venture Market is for entrepreneurial and development stage U.S. and international companies. To be eligible, companies must be current in their reporting, have a minimum bid
More informationOTC Pink Basic Disclosure Guidelines
OTC Pink Basic Disclosure Guidelines Federal securities laws, such as Rules 10b-5 and 15c2-11 of the Securities Exchange Act of 1934 ( Exchange Act ) as well as Rule 144 of the Securities Act of 1933 (
More informationApplication to Serve as an Attorney DAD or PAL or Investment Bank DAD or PAL
Application to Serve as an Attorney DAD or PAL or Investment Bank DAD or PAL This is an application ( Application ) for (i) a qualified attorney to serve as an Attorney Designated Advisor for Disclosure
More informationInterim Disclosure Statement (UNAUDITED)
Interim Disclosure Statement (UNAUDITED) For the twelve months ended December 31, 2017 and 2016 OTC Pink Basic Disclosure Guidelines 1) Name of the issuer and its predecessors IMD Companies, Inc. was formerly
More information<SEQUENCE>1 <FILENAME>cpst_sc13g.txt. SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G
1 cpst_sc13g.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Capstone Turbine Corporation (Name
More informationCommon stock prices 1. New York Stock Exchange indexes (Dec. 31,1965=50)2. Transportation. Utility 3. Finance
Digitized for FRASER http://fraser.stlouisfed.org/ Federal Reserve Bank of St. Louis 000 97 98 99 I90 9 9 9 9 9 9 97 98 99 970 97 97 ""..".'..'.."... 97 97 97 97 977 978 979 980 98 98 98 98 98 98 987 988
More informationSecurities and Exchange Commission. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.
Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* December 31, 2010 (Date of event which requires filing of this statement)
More informationSECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* OncoSec Medical Incoporated (Name of Issuer) Common Stock, par value $0.0001
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C BARNES & NOBLE, INC.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* BARNES & NOBLE, INC. (Name of Issuer) Common Stock, $.001
More informationPar or Stated Value: $ per share
OTC PINK Basic Disclosure 1) Name of the issuer and its predecessors (if any) In answering this item, please also provide any names used by predecessor entities in the past five years and the dates of
More informationKAYNE ANDERSON MIDSTREAM ENERGY FUND, INC. (Name of Issuer)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 KAYNE ANDERSON MIDSTREAM ENERGY FUND, INC. (Name of Issuer) Mandatory Redeemable
More informationSECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.
FORM SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Riot Blockchain, Inc. (Name of Issuer) Common Stock, no par
More informationManagement Report. Rocky Mountain Ayre Inc. For tine period ended September 30,2016. Prepared on
Management Report Rocky Mountain Ayre Inc. For tine period ended September 30,2016 Prepared on November 15,2016 Disclosure(s) 1) Name of the issuer and its predecessors (if any) In answering this item,
More informationCALAMOS GLOBAL TOTAL RETURN FUND (THE FUND
CALAMOS GLOBAL TOTAL RETURN FUND (THE FUND ) Supplement dated July 23, 2018 to the Prospectus and Statement of Additional Information both dated June 29, 2018, as supplemented on June 29, 2018 With this
More informationKINGSTONE COMPANIES, INC.
SECURITIES & EXCHANGE COMMISSION EDGAR FILING KINGSTONE COMPANIES, INC. Form: SC 13G Date Filed: 216-4-22 Corporate Issuer CIK: 33992 Copyright 216, Issuer Direct Corporation. All Right Reserved. Distribution
More informationSymmetry Technologies, Inc.
1) Name of the issuer and its predecessors (if any) Symmetry Technologies, Inc. Annual Report For the 12 Months ending June 30, 2017 In answering this item, please also provide any names used by predecessor
More informationSilvercrest Asset Management Group Inc. (Name of Issuer)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 2549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Silvercrest Asset Management Group Inc. (Name of Issuer)
More informationSCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) Cancer Genetics, Inc. (Name of Issuer) Common Stock (Title
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Adeptus Health Inc. (Name of Issuer) Class A Common Stock
More informationEveri Holdings Inc. (Name of Issuer)
SECURITIES AND EXCHANGE COMMISSION Washington, DC 2549 SCHEDULE 13G/A (Rule 13d-12) (Amendment No. 1) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS
More informationFiesta Restaurant Group, Inc. (Name of Issuer)
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) Under the Securities Exchange Act of 1934 Fiesta Restaurant Group, Inc. (Name of Issuer) Common Stock, par value $0.01
More informationAmerican Axle & Manufacturing Holdings, Inc. (Name of Issuer)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 0 SCHEDULE D Under the Securities Exchange Act of (Amendment No. ) American Axle & Manufacturing Holdings, Inc. (Name of Issuer) Common
More informationSECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.
FORM SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Capstone Turbine Corporation (Name of Issuer) Common Stock,
More informationCORPORATE COMPLIANCE POLICY MANUAL
CORPORATE COMPLIANCE POLICY MANUAL TRADING IN TENNECO SECURITIES 08/01/2006 Policy Number: 20-100 SUBJECT: TRADING IN TENNECO SECURITIES Application: Worldwide Strategic Business Units and Subsidiaries.
More informationJoint Proxy Statement/Prospectus MERGER PROPOSED YOUR VOTE IS VERY IMPORTANT
Joint Proxy Statement/Prospectus MERGER PROPOSED YOUR VOTE IS VERY IMPORTANT Dear Stockholder: On October 7, 2012, the boards of directors of NBT Bancorp Inc., or NBT, and Alliance Financial Corporation,
More informationAnnual Update December 2018
Annual Update December 2018 For The Earth Corporation Name of Issuer 20 E Thomas Rd., Suite 2200, Phoenix, AZ 85012 Office Address of Issuer (602) 612-8300 Telephone No of Issuer 22-3283541 Federal Employer
More informationCiner Resource Partners LLC
Ciner Resource Partners LLC INSIDER TRADING POLICY REVISED: February 10, 2017 TABLE OF CONTENTS Page I. SUMMARY OF CINER RESOURCE PARTNERS LLC POLICY CONCERNING INSIDER TRADING... 1 II. TRADING GUIDELINES...
More informationThe Securities and Exchange Commission ( Commission ) is (i) extending certain
SECURITIES AND EXCHANGE COMMISSION (Release No. 34-79833; File No. S7-27-11) January 18, 2017 Order Extending Certain Temporary Exemptions under the Securities Exchange Act of 1934 in Connection with the
More informationHARMAN INTERNATIONAL INDUSTRIES INC /DE/ Filed by WADDELL & REED FINANCIAL INC
HARMAN INTERNATIONAL INDUSTRIES INC /DE/ Filed by WADDELL & REED FINANCIAL INC FORM SC 13G/A (Amended Statement of Ownership) Filed 02/13/15 Address 400 ATLANTIC STREET SUITE 1500 STAMFORD, CT 06901 Telephone
More informationSECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A
Section 1: SC 13G/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS
More information24889/1 07/19/ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D Under the Securities Exchange Act of
24889/1 07/19/16 45390756.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* CANCER GENETICS, INC. (Name
More informationGROUPON, INC. Filed by KEYWELL BRADLEY A
GROUPON, INC. Filed by KEYWELL BRADLEY A FORM SC 13G (Statement of Ownership) Filed 02/14/12 Address 600 WEST CHICAGO AVENUE, SUITE 830 CHICAGO, IL 60610 Telephone (312) 604-5515 CIK 0001490281 Symbol
More informationHD SUPPLY HOLDINGS, INC. REGULATION FD DISCLOSURE POLICY
HD SUPPLY HOLDINGS, INC. REGULATION FD DISCLOSURE POLICY Policy Statement HD Supply Holdings, Inc. (the Company ) is committed to the full, fair, accurate, timely and understandable disclosure of information
More informationPursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (the Act ) 1 and Rule
SECURITIES AND EXCHANGE COMMISSION (Release No. 34-72019; File No. SR-MSRB-2014-03) April 25, 2014 Self-Regulatory Organizations; Municipal Securities Rulemaking Board; Notice of Filing and Immediate Effectiveness
More informationRecro Pharma, Inc. (Name of Issuer)
Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 2549 SCHEDULE 13G (Rule 13d-12) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c),
More informationSubject to certain exceptions, the Amendments require a registered investment adviser with custody of client assets to, among other things:
Private Funds Alert FEBRUARY 2010 Amendments To The Custody Rules: New Controls On Custody Of Client Assets Author Peter J. Bilfield Partner (203) 324-8151 pbilfield@goodwin.com www.shipmangoodwin.com
More informationAGENCY: Securities and Exchange Commission ( Commission ). ACTION: Notice of application for an order under sections 17(d) and 57(i) of the Investment
This document is scheduled to be published in the Federal Register on 01/17/2014 and available online at http://federalregister.gov/a/2014-00822, and on FDsys.gov 8011-01p SECURITIES AND EXCHANGE COMMISSION
More informationSpark Therapeutics, Inc.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Spark Therapeutics, Inc. (Name of Issuer) Common Stock,
More informationRE: LEGEND REMOVAL FOR THE SALE OF CERTIFICATES REPRESENTING SECURITIES OF SPINDLE, INC.
April 27, 2015 RE: LEGEND REMOVAL FOR THE SALE OF CERTIFICATES REPRESENTING SECURITIES OF SPINDLE, INC. Dear Shareholder: In response to your inquiry regarding removal of the Restricted legend on your
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE TO
sctoi0217_surgecomp.htm Form Type: SC TO-I Page 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) Of the Securities
More informationVMware, Inc. (Name of Issuer)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 13)* VMware, Inc. (Name of Issuer) Class A Common Stock, par
More informationNational American University Holdings, Inc.
SECURITIES & EXCHANGE COMMISSION EDGAR FILING National American University Holdings, Inc. Form: SC 13G Date Filed: 218-1-22 Corporate Issuer CIK: 1399855 Copyright 218, Issuer Direct Corporation. All Right
More informationSECURITIES AND EXCHANGE COMMISSION FORM SC 13G. Filing Date: SEC Accession No (HTML Version on secdatabase.
SECURITIES AND EXCHANGE COMMISSION FORM SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Filing
More informationManagement Report Rocky Mountain Ayre, Inc.
Management Report Rocky Mountain Ayre, Inc. For the period ended December 31, 2016 Prepared on: April 25, 2017 For management use only Table of Contents: Statement of Revenue & Expenses-Income Tax Basis
More informationXML Publisher Balance Sheet Vision Operations (USA) Feb-02
Page:1 Apr-01 May-01 Jun-01 Jul-01 ASSETS Current Assets Cash and Short Term Investments 15,862,304 51,998,607 9,198,226 Accounts Receivable - Net of Allowance 2,560,786
More informationAmendment No. 1 to SCHEDULE TO. Filing Party: Hospitality Investors Trust, Inc.
As filed with the Securities and Exchange Commission on May 24, 2018 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to SCHEDULE TO TENDER OFFER STATEMENT UNDER
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Algodon Wines & Luxury Development Group, Inc.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Algodon Wines & Luxury Development Group, Inc. (Name of
More informationin answering this item, please also provide any names used by predecessor entities in the past five years and the dates of the name changes.
Disclosure(s) 1) Name of the issuer and its predecessors (if any) in answering this item, please also provide any names used by predecessor entities in the past five years and the dates of the name changes.
More informationAs filed with the Securities and Exchange Commission on December 15, SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
Section 1: SC TO-I (SC TO-I) As filed with the Securities and Exchange Commission on December 15, 2016 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under
More informationIM Ref. No RESPONSE OF THE OFFICE OF CHIEF COUNSEL NexPoint Credit Strategies Fund DIVISION OF INVESTMENT MANAGEMENT File No.
June 26, 2013 IM Ref. No. 20134121542 RESPONSE OF THE OFFICE OF CHIEF COUNSEL NexPoint Credit Strategies Fund DIVISION OF INVESTMENT MANAGEMENT File No. 811-21869 Your letter dated June 20,2013 requests
More informationLegg Mason Investment Trust Legg Mason Opportunity Trust. Legg Mason Global Asset Management Trust Miller Income Opportunity Trust
Legg Mason Investment Trust Legg Mason Opportunity Trust Legg Mason Global Asset Management Trust Miller Income Opportunity Trust c/o Legg Mason Funds 100 International Drive Baltimore, Maryland 21202
More informationTaubman Centers, Inc. (Name of Issuer)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 2549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Taubman Centers, Inc. (Name of Issuer) Common Stock, $.1
More informationBlackstone Real Estate Income Trust, Inc.
SC 13D 1 d68353dsc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Blackstone Real Estate Income
More informationthe Securities and Exchange Commission ( Commission ), pursuant to Section 19(b)(1) of the
This document is scheduled to be published in the Federal Register on 05/02/2016 and available online at http://federalregister.gov/a/2016-10149, and on FDsys.gov 8011-01p SECURITIES AND EXCHANGE COMMISSION
More information*To be included in the OTC Pink Current Information tier, the transfer agent must be registered under the Exchange Act.
OTC Pink Basic Disclosure Guidelines 1) Name of the issuer and its predecessors (if any) In answering this item, please also provide any names used by predecessor entities in the past five years and the
More informationOTC Pink Basic Disclosure Guidelines
OTC Pink Basic Disclosure Guidelines Federal securities laws, such as Rules 10b-5 and 15c2-11 of the Securities Exchange Act of 1934 ( Exchange Act ) as well as Rule 144 of the Securities Act of 1933 (
More informationSELIGMAN NEW TECHNOLOGIES FUND II, INC. Investment Advisers Act - Section 205; and Rule February 7, 2002
SELIGMAN NEW TECHNOLOGIES FUND II, INC. Investment Advisers Act - Section 205; and Rule 205-3 February 7, 2002 RESPONSE OF THE OFFICE OF CHIEF COUNSEL DIVISION OF INVESTMENT MANAGEMENT IM Ref. No. 20011019110
More informationMEDICAL TRANSCRIPTION BILLING, CORP Filed by OMNI MEDICAL BILLING SERVICES, LLC
MEDICAL TRANSCRIPTION BILLING, CORP Filed by OMNI MEDICAL BILLING SERVICES, LLC FORM SC 13G (Statement of Ownership) Filed 08/22/14 Address 7 CLYDE ROAD SOMERSET SOMERSET, NJ 08873 Telephone 7328735133
More informationIssuer Appointment of an Investment Bank Designated Advisor for Disclosure
Issuer Appointment of an Investment Bank Designated Advisor for Disclosure Full Name and Address of the Issuer: (the Issuer ) Address: Full Name and Address of the Investment Bank Designated Advisor for
More informationFORM ADV UNIFORM APPLICATION FOR INVESTMENT ADVISER REGISTRATION AND REPORT BY EXEMPT REPORTING ADVISERS
FORM ADV UNIFORM APPLICATION FOR INVESTMENT ADVISER REGISTRATION AND REPORT BY EXEMPT REPORTING ADVISERS Primary Business Name: FUNDRISE ADVISORS, LLC CRD Number: 172036 Other Than Annual Amendment All
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 240.13d-1(a) AND AMENDMENTS THERETO FILED
More informationPartners Group Private Equity (Master Fund), LLC and Partners Group (USA) Inc.;
This document is scheduled to be published in the Federal Register on 05/20/2014 and available online at http://federalregister.gov/a/2014-11571, and on FDsys.gov SECURITIES AND EXCHANGE COMMISSION [Investment
More informationGENCO SHIPPING & TRADING LTD Filed by OZ MANAGEMENT LP
GENCO SHIPPING & TRADING LTD Filed by OZ MANAGEMENT LP FORM SC 13D/A (Amended Statement of Beneficial Ownership) Filed 4/25/14 Address 299 PARK AVENUE, 12TH FLOOR NEW YORK, NY, 1171 Telephone 646-443-855
More informationPharma-Bio Serv, Inc.
SECURITIES & EXCHANGE COMMISSION EDGAR FILING Pharma-Bio Serv, Inc. Form: SC 13D Date Filed: 2014-03-27 Corporate Issuer CIK: 1304161 Symbol: PBSV SIC Code: 8742 Fiscal Year End: 10/31 Copyright 2014,
More information2006 MUTUAL FUNDS AND INVESTMENT MANAGEMENT CONFERENCE. Sub-Advised Funds: The Legal Framework
2006 MUTUAL FUNDS AND INVESTMENT MANAGEMENT CONFERENCE I. Introduction Sub-Advised Funds: The Legal Framework Arthur J. Brown * Partner Kirkpatrick & Lockhart Nicholson Graham LLP A fund can internally
More informationPossible OFAC. Derogatory Legal 0 ($0) Address 1500 PENNSYLVANIA AVENUE, WASHINGTON, DC 20220
Company Name Safe Number E PLURRIBUS UNUMTHE UNITED STATES OF AMERICA (GOVERNMENT) US01049182 Rating E DBT Credit Limit Not Rated Insufficient Information Derogatory Legal 0 ($0) Possible OFAC No Payment
More informationNeuro-HiTech, Inc.: a Delaware Corporation. OTC Disclosures for the Quarter ended September 30, 2018
Neuro-HiTech, Inc. a Delaware Corporation OTC Disclosures for the Quarter ended September 30, 2018 OTC Pink Basic Disclosure Guidelines 1) Name of the issuer and its predecessors (if any) In answering
More informationOCWEN FINANCIAL CORPORATION (Name of Issuer)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment )* OCWEN FINANCIAL CORPORATION (Name of Issuer) Common Stock, par
More informationTERMS OF REFERENCE FOR THE FINANCE AND AUDIT COMMITTEE
I. PURPOSE A. The primary function of the Finance and Audit Committee (the Committee ) is to assist the Board in fulfilling its oversight responsibilities by reviewing: i) the accuracy of financial information
More informationSECURITIES & EXCHANGE COMMISSION EDGAR FILING. Support.com, Inc. Form: SC 13G/A. Date Filed:
SECURITIES & EXCHANGE COMMISSION EDGAR FILING Support.com, Inc. Form: SC 13G/A Date Filed: 2017-11-15 Corporate Issuer CIK: 1104855 Copyright 2017, Issuer Direct Corporation. All Right Reserved. Distribution
More informationQUARTERLY REPORT TESORO ENTERPRISES, INC. SEPTEMBER 30, 2015
QUARTERLY REPORT TESORO ENTERPRISES, INC. SEPTEMBER 30, 2015 OTC Pink Basic Disclosure Guidelines 1) Name of the issuer and its predecessors (if any) In answering this item, please also provide any names
More informationSECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Amendment No. 3. Under the Securities Exchange Act of 1934
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Amendment No. 3 Under the Securities Exchange Act of 1934 Vuzix Corporation (Name of Issuer) Common Stock, par value $0.001 per
More informationSECURITIES AND EXCHANGE COMMISSION. Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934.
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) MGIC INVESTMENT CORP. (Name of Issuer) Common Stock (Title of Class of
More informationSECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Protalix BioTherapeutics, Inc. (Name of Issuer) Common Stock, par value
More informationFS INVESTMENT CORPORATION II OFFER TO PURCHASE SHARES OF COMMON STOCK FOR CASH ON APRIL 2, 2018
FS INVESTMENT CORPORATION II OFFER TO PURCHASE SHARES OF COMMON STOCK FOR CASH ON APRIL 2, 2018 LETTER OF TRANSMITTAL MUST BE RECEIVED BY FS INVESTMENT CORPORATION II ON OR BEFORE MARCH 28, 2018 To the
More informationResource Real Estate Opportunity REIT, Inc. (Exact name of registrant as specified in its charter)
As filed with the Securities and Exchange Commission on May 31, 2016 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE
More information